The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and represent the first new class of pain medications in 20 years—and the first non ...

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

The drug offers a non-addictive alternative to opioids, marking 'an important public health milestone in acute pain ...

Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...

The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

While America retains a gold standard for airline safety, there are stresses on the US air travel system that have been ...

(CNN) – The U.S. Food and Drug Administration approved the first new type of pain medication in more than two decades, and it’s not an opioid. The drug is suzetrigine under the brand name Journavx. It ...

Trust is a cornerstone of meaningful relationships. When dealing with businesses and brands, it's often the deciding factor that separates companies we rely on from the ones we don't. It's about ...

Advertisment With millions of devotees gathering from around the world, the Maha Kumbh Mela 2025 has become a prime opportunity for brands to connect with this vast audience. From opening ...